- 24/7 Wall St.•yesterday
The pricier the market gets, the more it makes sense to stay with industry leaders, especially those that have paid and raised their dividends consistently.
- PR Newswire•4 days agoNew Study Demonstrates Spinal Cord Stimulation Can Reduce or Stabilize Opioid Use Among Chronic Pain Patients
ABBOTT PARK, Ill., Jan. 20, 2017 /PRNewswire/ -- New research has found spinal cord stimulation (SCS) therapy can be key to reducing or stabilizing the use of opioids in patients battling chronic pain. In a new study, researchers examined opioid usage data from more than 5,400 patients both prior to and after receiving an SCS system implant. Researchers have found that average daily opioid use declined or stabilized for patients receiving a successful SCS system compared to patient use of opioids prior to an implant.
ABT : Summary for Abbott Laboratories Common Stoc - Yahoo Finance
Abbott Laboratories (ABT)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||40.12 - 40.50|
|52 Week Range||36.00 - 45.79|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||26.61|
|Dividend & Yield||1.06 (2.62%)|
|1y Target Est||N/A|